FDA/DEA Ban Of Andro Sought By Blue Cross & Blue Shield Foundation
This article was originally published in The Tan Sheet
Executive Summary
A youth sports advocacy group is attempting to halt the sale and use of androstenedione-containing dietary supplements with a dual-pronged initiative aimed at Major League Baseball players and federal regulators, including FDA.